Target intelligence / Profile preview

Common Krait long-chain three-finger alpha-neurotoxins (LαNTx)

Target
LαNTx
Molecular classification
Three-finger toxin (3FTx) family, Alpha-neurotoxin subfamily, Long-chain neurotoxin, Other
01

Overview

Common Krait long-chain three-finger alpha-neurotoxins are a group of potent venom proteins produced by the snake Bungarus caeruleus. These toxins belong to the three-finger toxin (3FTx) superfamily and are characterized by a core of four or five disulfide bonds and three protruding loops. They function as competitive antagonists of nicotinic acetylcholine receptors (nAChRs) at the postsynaptic membrane of the neuromuscular junction. By binding with high affinity and slow reversibility to these receptors, they block the action of acetylcholine, leading to progressive muscle paralysis and potentially fatal respiratory failure. In the context of snakebite envenomation, these toxins are the primary targets for neutralization by polyvalent and monovalent antivenoms. Therapeutic challenges include the rapid onset of paralysis and the risk of hypersensitivity reactions to animal-derived antivenoms. These toxins are also valuable tools in neuroscience research for studying the structure and function of nAChRs.

Other names
Bungarus caeruleus alpha-neurotoxinsLong-chain alpha-neurotoxinsKappa-bungarotoxinsAlpha-delta-bungarotoxin-4Postsynaptic neurotoxins
02

Mechanism of action

Neutralization of toxin activity by antibody binding, preventing the toxin from occupying nicotinic acetylcholine receptors at the neuromuscular junction.

03

Biological functions

Nicotinic acetylcholine receptor antagonismNeuromuscular blockadeInhibition of synaptic transmissionOther
04

Disease associations

Snakebite envenomationNeuromuscular paralysisRespiratory failureOther
05

Safety considerations

Rapid onset of life-threatening respiratory paralysisRisk of antivenom-induced anaphylaxisSerum sickness following antivenom administrationPotential for rebound envenomation
06

Interacting drugs

Polyvalent antivenom

1 more in the full profile.

07

Biomarkers

Serum venom levels (ELISA)Single-fiber electromyography (sfEMG) jitterClinical signs of neurotoxicity (e.g., ptosis, ophthalmoplegia)

Beyond the preview

Go deeper on Common Krait long-chain three-finger alpha-neurotoxins (LαNTx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Common Krait long-chain three-finger alpha-neurotoxins (LαNTx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call